• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Wearable Sensor Measures Sweat Lactate Levels During Exercise

by Jasmine Pennic 07/19/2023 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– A team of Japanese researchers has developed a wearable device that can measure how hard one is exercising by analyzing their sweat. 

– Their findings have been published in the journal ACS Sensors. The device continuously monitors the level of lactate in our sweat, which is a good indicator of exercise intensity. This technology can be valuable for athletes and fitness enthusiasts to manage their training and monitor their overall health.

Leveraging Lactate Level in Sweat as a Biomarker

Human sweat is a rich source of health information, offering insights into a person’s hydration level, electrolyte balance, and overall physiological state. For instance, lactate level in sweat is a useful biomarker of exercise intensity. Its measurement can help estimate the amount of lactic acid in the blood and, in turn, predict muscle fatigue.

Today, wearable sensors make it possible to continuously monitor biomarkers such as sweat lactate. Using the latest microfluidics technology, scientists have developed devices that convey minuscule amounts of sweat to tiny chemical sensors, which can transmit their measurements in real time wirelessly. However, one common problem in such devices is that their microfluidic channels tend to trap air bubbles present in the sweat. If these bubbles cover the sensor’s electrodes, the measurements get interrupted, interfering with the continuous monitoring of the target biomarker. 

Research Background/Protocols

To address this issue, a research team, led by Associate Professor Isao Shitanda from Tokyo University of Science (TUS) in Japan, has come up with a novel microfluidic sweat lactate sensor whose measurements remain unaffected by the air bubbles. Their study, made available online on 22 May 2023 and published in ACS Sensors on 23 June 2023, was co-authored by Dr. Masahiro Motosuke, Dr. Tatsunori Suzuki, Dr. Shinya Yanagita, and Dr. Takahiro Mukaimoto from TUS.

The proposed wearable device consists of a relatively simple layered structure—a conventional lactate oxidase sensor attached via double-sided tape to a microfluidic system made of a silicone polymer. When the person wearing the device begins to perspire, the sweat enters the microfluidic channels via four inlets and flows toward a reservoir near which the electrodes are located. Old sweat exits the system through an outlet as new sweat enters, and a small wireless transmitter reports the measured lactate levels.

The key innovation in the proposed design was the use of a larger-than-usual sweat reservoir. “By increasing the length of the reservoir in the microfluidic channel, a space of approximately four microliters was created for trapping any air bubbles that infiltrate the device, thereby preventing them from contacting the electrodes of the sensor,” explains Dr. Shitanda. 

The researchers tested their sensor in a series of laboratory experiments. They verified that the bubble-trapping region worked as intended by injecting bubbles into the device while measuring lactate levels in artificial sweat. In addition, the measurements were not affected by the sweat flow rate, and the response of the sensor remained stable for approximately two hours. Lastly, the researchers tested the device on a male volunteer who exercised on a stationary bike for almost an hour. The sensor showed a lactate concentration correlation ranging from 1 to 50 mM as well as a correlation between sweat and blood lactate levels.

Overall, the results of this study hint at the potential of wearable microfluidic sensors for monitoring sweat biomarkers during exercise. 

“Since the microfluidic system of the proposed lactate sensor is fabricated from a soft, flexible, and non-irritating material, it could be used to continuously monitor lactate levels in sweat, especially in sports and medicine,” remarks Dr. Shitanda. “Wearable lactate sensors may become useful condition management tools in sports such as soccer and basketball, allowing team managers to know when it’s best to replace a player.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |